-
Altered gene methylation in cancer
-
Universality of epigenetic changes in human cancer
-
CpG-cluster methylation marks inactive promoters on inactive X-chromosome
-
Hypermethylation of calcitonin
-
Parent-of-origin-specific loss of heterozygosity in tumours
-
Hypermethylation of a tumour-suppressed gene
-
Promoter methylation enforces gene silencing on the inactive X chromosome
-
Human trithorax is a proto-oncogene
-
Insulin-like growth factor-2 loss of imprinting in cancer
-
Several epigenetic detects linked to Beckwith-Wiedemann syndrome
-
Functional association between epigenetics and tumour suppression
-
Histone deacetylation in X inactivation
-
Gatekeeper role for epigenetic alterations in cancer
-
Retinoblastoma tumour-suppressor genes sets epigenetic states in SWI/SNF complex
-
Mouse model for cancer epigenetics
-
Frequent tumour suppression gene methylation in cancer
-
Chromatin-remodeling complex mutated in human cancers
-
DNA hypomethylation linked to chromosomal instability
-
Epigenotype-phenotype analysis shows gatekeeper role in human cancer system
-
Altered histone lysine methylation at silenced tumour supressor loci
-
Renaissance of hypomethylation and gene activation in cancer
-
Polycomb proteins hypothesized to account for gene silencing in cancer
-
DNA hypomethylation linked to environmental toxins and diet
-
Clinical trials of 5 aza 2 deoxycytidine and trichostain A therapy in cancer patients